Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 68.2 TWD 0.89% Market Closed
Market Cap: 11.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

Tanvex BioPharma Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tanvex BioPharma Inc
Additional Paid In Capital Peer Comparison

Comparables:
688235
6550

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Tanvex BioPharma Inc
TWSE:6541
Additional Paid In Capital
NT$13.6B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Additional Paid In Capital
ÂĄ81.4B
CAGR 3-Years
15%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Polaris Group
TWSE:6550
Additional Paid In Capital
NT$11.7B
CAGR 3-Years
30%
CAGR 5-Years
18%
CAGR 10-Years
N/A

See Also

What is Tanvex BioPharma Inc's Additional Paid In Capital?
Additional Paid In Capital
13.6B TWD

Based on the financial report for Jun 30, 2024, Tanvex BioPharma Inc's Additional Paid In Capital amounts to 13.6B TWD.

What is Tanvex BioPharma Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
13%

Over the last year, the Additional Paid In Capital growth was 9%. The average annual Additional Paid In Capital growth rates for Tanvex BioPharma Inc have been 12% over the past three years , 13% over the past five years .

Back to Top